AD

Addus HomeCare Corporation

ADUSHealthcareNASDAQ

Medical Care Facilities · Last scanned Oct 26, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$1.42B
+23.2% YoY
Net Income
$95.9M
+30.3% YoY
EBITDA
$157.5M
+30.6% YoY
Free Cash Flow
$116.3M

Scan Results

Daily timeframe
5 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 13▲ MACD Positive CrossoverHistogram +0.2745, positive momentum
Oct 12▲ MACD Positive CrossoverHistogram +0.1263, positive momentum
About Addus HomeCare Corporation

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or. The company carries a $2.27B market cap, placing it firmly in the mid-cap category. The company operates through three segments: Personal Care, Hospice, and Home Health.

Where ADUS stands vs its 150-day and 200-day moving averages

As of the October 13, 2026 close, ADUS finished 10.23% above its 150-day moving average ($104.76) and 9.26% above its 200-day moving average ($105.69). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is ADUS overbought or oversold?

At the October 13, 2026 close, ADUS's RSI(14) was 54.8, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$2.27B
P/E (TTM)21.33
Fwd P/E16.21
EPS$5.71
Beta0.83
52W Change+0.3%
Dividend Yield0.00%
ROE9.7%
Analysis

Addus HomeCare Corporation carries $108.8M in total debt against $99.6M in cash reserves — debt is modestly above the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow comes in at $116.3M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 9.7% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 6.3% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $951.1M (2022) to $1.42B (2025), reflecting a 50% increase over the period.

As with any equity investment, ADUS carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. Understanding these risk dimensions helps frame what to watch going forward as conditions evolve for Addus HomeCare Corporation and its sector.

Links
More Healthcare stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms